Human tumor-derived exosomes downmodulate NKG2D expression and inhibit the binding of Abs with tumor cells, reducing the antibody-dependent cellular cytotoxicity (ADCC) (Clayton et al., 2008; Ashiru et al., 2010; Battke et al., 2011). The gene discussed is KLRK1; the disease is neoplasm.